title: Improving primary care for depression in late life: the design of a multicenter randomized trial.
abstract: BACKGROUND
  Late life depression can be successfully treated with antidepressant medications or psychotherapy, but few depressed older adults receive effective treatment.
  
  
  METHODS
  A randomized controlled trial of a disease management program for late life depression.
  
  
  METHODS
  Approximately 1,750 older adults with major depression or dysthymia are recruited from seven national study sites.
  
  
  METHODS
  Half of the subjects are randomly assigned to a collaborative care program where a depression clinical specialist supervised by a psychiatrist and a primary care expert supports the patient's regular primary care provider to treat depression. Intervention services are provided for 12 months using antidepressant medications and Problem Solving Treatment in Primary Care according to a stepped care protocol that varies intervention intensity according to clinical needs. The other half of the subjects are assigned to care as usual.
  
  
  RESULTS
  Subjects are independently assessed at baseline, 3 months, 6 months, 12 months, 18 months, and 24 months. The evaluation assesses the incremental cost-effectiveness of the intervention compared with care as usual. Specific outcomes examined include care for depression, depressive symptoms, health-related quality of life, satisfaction with depression care, health care costs, patient time costs, market and nonmarket productivity, and household income.
  
  
  CONCLUSIONS
  The study blends methods from health services and clinical research in an effort to protect internal validity while maximizing the generalizability of results to diverse health care systems. We hope that this study will show the cost-effectiveness of a new model of care for late life depression that can be applied in a range of primary care settings.
authors.affiliation: Center for Health Services Research, UCLA Neuropsychiatric Institute, Los Angeles, CA, USA. unutzer@ucla.edu
authors.forename: J
authors.initials: J
authors.lastname: Unützer
authors.forename: W
authors.initials: W
authors.lastname: Katon
authors.forename: J W
authors.initials: JW
authors.lastname: Williams
authors.forename: C M
authors.initials: CM
authors.lastname: Callahan
authors.forename: L
authors.initials: L
authors.lastname: Harpole
authors.forename: E M
authors.initials: EM
authors.lastname: Hunkeler
authors.forename: M
authors.initials: M
authors.lastname: Hoffing
authors.forename: P
authors.initials: P
authors.lastname: Arean
authors.forename: M T
authors.initials: MT
authors.lastname: Hegel
authors.forename: M
authors.initials: M
authors.lastname: Schoenbaum
authors.forename: S M
authors.initials: SM
authors.lastname: Oishi
authors.forename: C A
authors.initials: CA
authors.lastname: Langston
mesh_terms: D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003866:Depressive Disorder / Q000628:therapy*; D019468:Disease Management; D019263:Dysthymic Disorder / Q000628:therapy; D005260:Female; D006299:Health Services for the Aged / Q000191:economics / Q000592:standards*; D006801:Humans; D007318:Inservice Training; D008297:Male; D017063:Outcome Assessment, Health Care; D010348:Patient Care Team; D010353:Patient Education as Topic; D011320:Primary Health Care / Q000191:economics / Q000592:standards*; D012985:Software Design; D014481:United States
chemical_list: D000928:Antidepressive Agents